DCF — CLEVELAND CLINIC REHABILITATION HOSP
Enterprise Value: $73.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$73.8M
Enterprise Value
$18.9M
PV of Cash Flows
$54.9M
PV of Terminal Value
$88.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $114.7M | $10.0M | 9.0% | $3.4M | $3.1M |
| Year 2 | $118.2M | $11.5M | 10.0% | $4.4M | $3.6M |
| Year 3 | $121.7M | $13.1M | 11.0% | $5.4M | $4.1M |
| Year 4 | $125.3M | $14.1M | 11.0% | $6.0M | $4.1M |
| Year 5 | $129.1M | $14.8M | 11.0% | $6.5M | $4.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $73.8M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$111.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0824203306422038
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5